Gerresheimer AG, GlaxoSmithKline plc and LyondellBasell Industries Holdings B.V. are Dominating the Global Blow-Fill-Seal Equipment Market in 2019

Global Blow-Fill-Seal Equipment Market is expected to grow with the CAGR of 6.2% in the forecast period of 2020 to 2027. The years considered for study are as mentioned below:

Access Full Report @

Global blow-fill-seal equipment market is a highly consolidated market, which includes specific number of key players as well as local players. The market has witnessed increased strategic developments owing to favourable market scenario.

The major players dealing in global blow-fill-seal equipment market are introducing strong range of product portfolio. This helped companies to maximize the sales with enhanced product portfolio. For instance, In November 2019, Gerresheimer AG subsidiary Sensile Medical entered a partnership with Swiss biopharmaceutical company SQ Innovation AG. The partnership focussed on the manufacturing of micro pump to treatment edema which occurs in heart failure cases. This adds the sales of Gerresheimer AG increasing the revenue as well.

Gerresheimer AG, is the dominating player in global blow-fill-seal equipment market. The other key players existing in the market GlaxoSmithKline plc, LyondellBasell Industries Holdings B.V., Weiler Engineering, Inc., Rommelag Kunststoff-Maschinen Vertriebsgesellschaft GmbH, Serac Group, GEA Group Aktiengesellschaft, SIDEL , BREVETTI ANGELA S.r.l., S.I.P.A. S.p.A, Adinath International, Asept Pak, Inc., BioConnection, BirgiMefar, Catalent, Inc , Curida AS , HealthStar, Hunan Chinasun Pharmaceutical Machinery Co., Ltd. , Marchesini Group S.p.A., NEURAXPHARM, pharmapack technologies corporation, Plastikon Industries Inc, Rao Design International, Recipharm AB, SALVAT, Shanghai Pharmaceutical Machinery Co., Ltd, The Ritedose Corporation, Unicep , Unipharma, LLC, Unither, Unolab Manufacturing SL. among others.

Blow-fill-seal Equipment Market

Gerresheimer AG

Gerresheimer AG is headquartered in Düsseldorf, Germany and was found in 1864. The focus of the company is to deal with products of specialty glass and plastic products with application in pharmaceutical packaging for the safety of the product. The deals with various segments such as plastics and devices, primary packaging glass, advanced technologies among which primary packaging glass is the market focussed segment. The company offers various product categories such as pharmaceutical primary packaging, customer-specific drug delivery systems, medical devices and diagnostics products, micro pumps, fragrance & cosmetics, food & beverage, nutritional supplements, life science among which Pharmaceutical Primary Packaging is the market focussed segment.

For instance,

  • In October 2020, Gerresheimer AG focuses on recycling management in the development and industrial production and decoration of glass flacons, jars and bottles for fragrances and decorative cosmetics and beauty care products that uses more recycles glass material.

The company has wide global presence across the globe such as Asia-Pacific, Europe, Middle East & Africa, South America, and North America.

GlaxoSmithKline plc

GlaxoSmithKline plc. was founded in 1715 and is headquartered in England, UK. The company focuses on the manufacturing of innovative pharmaceuticals medicines, vaccines and consumer healthcare products. The company offers various products such as our prescription medicines, our vaccines, our consumer healthcare products, viiv healthcare, stiefel dermatology among which our prescription medicines is the market focussed category.

For instance,

  • In September 2020, GlaxoSmithKline plc (GSK) announced that US Food and Drug Administration (FDA) has approved Nucala (mepolizumab). This will help in the treatment of adult and paediatric patients aged 12 years and older with Hypereosinophilic Syndrome (HES). This will increase sales and revenue of GlaxoSmithKline plc (GSK).

The company has wide global presence in Americas, Asia-Pacific, Middle East and Africa, Europe and earning revenue from its subsidiaries such as GlaxoSmithKline Pharmaceuticals Ltd (India), Tesaro (U.S.), Stiefel Laboratories (Germany), Alacer Corp. (U.S.), Sirtris Pharmaceuticals (U.S.), Glaxosmithkline Biologicals (Belgium), GLAXOSMITHKLINE SPA (Italy), Allen and Hanburys (U.K.) and many more.

LyondellBasell Industries Holdings B.V

LyondellBasell Industries Holdings B.V founded in 1953 and is headquartered in Houston, United States. The company is engaged in the manufacturing of chemicals, polymers, fuels and others. The company offers various products such as thylene, propylene, propylene oxide, ethylene oxide, tertiary butyl alcohol, methanol, acetic acid and their derivatives and the market focused product is plastic compounds in blow-fill-seal equipment. The company has wide global presence in Asia-Pacific, North America, Europe, Middle East and Africa, South America and Australia and New Zealand.

For instance,

  • In June 2020, LyondellBasell’s Spheripol technology was adopted by Indian Oil Corporation Ltd. The technology will be used in the construction of for a 450 KTA polypropylene plant with more than 27 million tons capacity. This will help in increase in sales and revenue.

The company has wide global presence in Asia-Pacific, Europe, Central America, North America, and South America, and earning revenue from subsidiary such as Basell Holdings B.V. (Netherlands).